458 related articles for article (PubMed ID: 30290004)
1. Point-of-care screening for sickle cell disease in low-resource settings: A multi-center evaluation of HemoTypeSC, a novel rapid test.
Steele C; Sinski A; Asibey J; Hardy-Dessources MD; Elana G; Brennan C; Odame I; Hoppe C; Geisberg M; Serrao E; Quinn CT
Am J Hematol; 2019 Jan; 94(1):39-45. PubMed ID: 30290004
[TBL] [Abstract][Full Text] [Related]
2. Multicenter Evaluation of HemoTypeSC as a Point-of-Care Sickle Cell Disease Rapid Diagnostic Test for Newborns and Adults Across India.
Mukherjee MB; Colah RB; Mehta PR; Shinde N; Jain D; Desai S; Dave K; Italia Y; Raicha B; Serrao E
Am J Clin Pathol; 2020 Jan; 153(1):82-87. PubMed ID: 31433854
[TBL] [Abstract][Full Text] [Related]
3. A rapid, inexpensive and disposable point-of-care blood test for sickle cell disease using novel, highly specific monoclonal antibodies.
Quinn CT; Paniagua MC; DiNello RK; Panchal A; Geisberg M
Br J Haematol; 2016 Nov; 175(4):724-732. PubMed ID: 27605462
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of a rapid, point-of-care lateral flow immunoassay for the diagnosis of sickle cell disease.
McGann PT; Schaefer BA; Paniagua M; Howard TA; Ware RE
Am J Hematol; 2016 Feb; 91(2):205-10. PubMed ID: 26537622
[TBL] [Abstract][Full Text] [Related]
5. Extremely high birth prevalence of sickle cell disease in rural Tanzania.
Eastburg L; Peckham A; Kawira E; Chirangi B; Adler D; Akungo BD; Smart LR; Ambrose EE
Pediatr Blood Cancer; 2020 Nov; 67(11):e28620. PubMed ID: 32803850
[TBL] [Abstract][Full Text] [Related]
6. HemoTypeSC, a low-cost point-of-care testing device for sickle cell disease: Promises and challenges.
Nnodu O; Isa H; Nwegbu M; Ohiaeri C; Adegoke S; Chianumba R; Ugwu N; Brown B; Olaniyi J; Okocha E; Lawson J; Hassan AA; Diaku-Akinwumi I; Madu A; Ezenwosu O; Tanko Y; Kangiwa U; Girei A; Israel-Aina Y; Ladu A; Egbuzu P; Abjah U; Okolo A; Akbulut-Jeradi N; Fernandez M; Piel FB; Adekile A
Blood Cells Mol Dis; 2019 Sep; 78():22-28. PubMed ID: 30773433
[TBL] [Abstract][Full Text] [Related]
7. Implementing newborn screening for sickle cell disease as part of immunisation programmes in Nigeria: a feasibility study.
Nnodu OE; Sopekan A; Nnebe-Agumadu U; Ohiaeri C; Adeniran A; Shedul G; Isa HA; Owolabi O; Chianumba RI; Tanko Y; Iyobosa JH; Adekile AD; Olopade OI; Piel FB
Lancet Haematol; 2020 Jul; 7(7):e534-e540. PubMed ID: 32589979
[TBL] [Abstract][Full Text] [Related]
8. Potential for a large-scale newborn screening strategy for sickle cell disease in Mali: A comparative diagnostic performance study of two rapid diagnostic tests (SickleScan® and HemotypeSC®) on cord blood.
Guindo A; Cisse Z; Keita I; Desmonde S; Sarro YDS; Touré BA; Baraika MA; Tessougué O; Guindo P; Coulibaly M; Traore O; Sylla N; Diassana M; Saye A; Picot V; Lauressergues E; Leroy V
Br J Haematol; 2024 Jan; 204(1):337-345. PubMed ID: 37728227
[TBL] [Abstract][Full Text] [Related]
9. Newborn Screening for Sickle Cell Disease Using Point-of-Care Testing in Low-Income Setting.
Alvarez OA; Hustace T; Voltaire M; Mantero A; Liberus U; Saint Fleur R
Pediatrics; 2019 Oct; 144(4):. PubMed ID: 31530717
[TBL] [Abstract][Full Text] [Related]
10. Newborn blood spot screening for sickle cell disease by using tandem mass spectrometry: implementation of a protocol to identify only the disease states of sickle cell disease.
Moat SJ; Rees D; King L; Ifederu A; Harvey K; Hall K; Lloyd G; Morrell C; Hillier S
Clin Chem; 2014 Feb; 60(2):373-80. PubMed ID: 24158758
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous point-of-care detection of anemia and sickle cell disease in Tanzania: the RAPID study.
Smart LR; Ambrose EE; Raphael KC; Hokororo A; Kamugisha E; Tyburski EA; Lam WA; Ware RE; McGann PT
Ann Hematol; 2018 Feb; 97(2):239-246. PubMed ID: 29147848
[TBL] [Abstract][Full Text] [Related]
12. New approach to accurate interpretation of sickle cell disease newborn screening by applying multiple of median cutoffs and ratios.
Allaf B; Patin F; Elion J; Couque N
Pediatr Blood Cancer; 2018 Sep; 65(9):e27230. PubMed ID: 29781571
[TBL] [Abstract][Full Text] [Related]
13. Determination of birth prevalence of sickle cell disease using point of care test HemotypeSC™ at Rundu Hospital, Namibia.
Mano RM; Kuona P; Misihairabgwi JM
BMC Pediatr; 2024 May; 24(1):323. PubMed ID: 38730340
[TBL] [Abstract][Full Text] [Related]
14. Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screening.
Kunz JB; Awad S; Happich M; Muckenthaler L; Lindner M; Gramer G; Okun JG; Hoffmann GF; Bruckner T; Muckenthaler MU; Kulozik AE
Ann Hematol; 2016 Feb; 95(3):397-402. PubMed ID: 26658910
[TBL] [Abstract][Full Text] [Related]
15. Feasibility and acceptability of early infant screening for sickle cell disease in Lagos, Nigeria-A pilot study.
Oluwole EO; Adeyemo TA; Osanyin GE; Odukoya OO; Kanki PJ; Afolabi BB
PLoS One; 2020; 15(12):e0242861. PubMed ID: 33270733
[TBL] [Abstract][Full Text] [Related]
16. Potential of point of care tests for newborn screening for sickle cell disease: Evaluation of HemotypeSC™ and sickle SCAN® in Tanzania.
Christopher H; Josephat E; Kaywanga F; Saul S; Mshana I; Kunambi P; Nasser A; Chamba C; Makani J; Nkya S
Int J Lab Hematol; 2022 Oct; 44(5):959-965. PubMed ID: 35775883
[TBL] [Abstract][Full Text] [Related]
17. A Paper-Based Test for Screening Newborns for Sickle Cell Disease.
Piety NZ; George A; Serrano S; Lanzi MR; Patel PR; Noli MP; Kahan S; Nirenberg D; Camanda JF; Airewele G; Shevkoplyas SS
Sci Rep; 2017 Apr; 7():45488. PubMed ID: 28367971
[TBL] [Abstract][Full Text] [Related]
18. HemoTypeSC point-of-care testing shows high sensitivity with alkaline cellulose acetate hemoglobin electrophoresis for screening hemoglobin SS and SC genotypes.
Adegoke SA; Oladimeji OI; Akinlosotu MA; Akinwumi AI; Matthew KA
Hematol Transfus Cell Ther; 2022; 44(3):341-345. PubMed ID: 33531281
[TBL] [Abstract][Full Text] [Related]
19. Newborn screening for sickle cell disease in Kisangani, Democratic Republic of the Congo: an update.
Kasai ET; Gulbis B; Ntukamunda JK; Bours V; Batina Agasa S; Marini Djang'eing'a R; Boemer F; Katenga Bosunga G; Ngbonda Dauly N; Sokoni Vutseme J; Boso Mokili B; Alworong'a Opara JP
Hematology; 2023 Dec; 28(1):2213043. PubMed ID: 37183964
[TBL] [Abstract][Full Text] [Related]
20. Early diagnosis of sickle cell disease at birth hospitals and vaccination centers in Angola using point-of-care tests.
Olaniyan HS; Briscoe C; Muhongo M; Pascoal R; Armando A; Santos B; McGann PT
Blood Adv; 2023 Oct; 7(19):5860-5867. PubMed ID: 37399450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
